Edward L. Barnes MD MPH, from the University of North Carolina at Chapel Hill, answers questions about the management of pouchitis in ulcerative colitis, a topic he discussed during his session at the...
Stephen Hanauer, MD, from Northwestern Medicine, answers our questions about the use of biosimilars in the management of IBD ahead of his presentation at the Advances in Inflammatory Bowel Diseases (AIBD)...
Because of its potential to lead to serious consequences, the inadequate treatment of inflammatory bowel disease can be viewed as an adverse event, according to Miguel Regueiro, MD, from Cleveland Clinic....
Ashwin N. Ananthakrishnan, MD, MPH, from Massachusetts General Hospital, answers our questions about how to manage IBD in older adults, ahead of his presentation at the Advances in Inflammatory Bowel...
Therapeutic drug monitoring has the potential to optimize inflammatory bowel disease management. Siddharth Singh, MD, MS, answers our questions about this important topic in advance of his presentation at...
